Ubiquitin Isopeptidase Inhibitor I, G5 is a cell-permeable cross-conjugated α,β-unsaturated dienone compound reported to induce caspase activation and apoptosis via the apoptosome-independent mitochondrial pathway by selectively inhibiting ubiquitin isopeptidase activity. The cellular expression of Bax and Bak is essential for G5-activated apoptosis, while Bcl-2 appears to protect cells against the effect of G5. G5 is reported to exhibit similar pharmacological effects as Ubiquitin Isopeptidase Inhibitor II, F6 but is reported to be more potent (sc-296678). Additionally, at higher concentrations, it has been shown to induce necrosis in apoptosis-resistant MEFs-DKO.
1. Aleo, E., et al. 2006. Cancer Res. 66: 9235-9244. PMID: 16982768
2. Fontanini, A., et al. 2009. J. Biol. Chem. 284: 8369-8381. PMID: 19139105
Vedi quanti altri hanno usato Ubiquitin Isopeptidase Inhibitor I, G5 (CAS 108477-18-5). Clicca sulla voce per laccesso a PubMed .
PMID: # 25959059 Koumbadinga, GA. et al. 2015. Biochimica et biophysica acta. 1849: 1095-103.
PMID: # 24985478 Rush, J.S. et al. 2014. Investigative ophthalmology & visual science. 55: 4691-9.
La Santa Cruz Biotechnology, Inc. è un leader mondiale nello sviluppo di prodotti per il mercato della ricerca biomedica. Chiamaci al numero gratuito 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. Tutti i diritti riservati. "Santa Cruz Biotechnology", ed il logo Santa Cruz Biotechnology, Inc."Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", il logo San Juan Ranch, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", ed "EZ Touch" sono marchi registrati dalla Santa Cruz Biotechnology, Inc.
Tutti i marchi sono proprietà dei rispettivi proprietari.